Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL
Pharma
Pfizer charges $3.5M for its first FDA-approved gene therapy
Pfizer has gained its first FDA approval for a gene therapy, scoring with Beqvez for hemophilia B and will charge $3.5M for the one-time therapy.
Kevin Dunleavy
Apr 26, 2024 10:19am
With proposal, CSL Vifor attempts to avoid antitrust penalty
Apr 19, 2024 11:57am
CSL Behring cuts headcount by 65 at Illinois plant
Apr 15, 2024 1:08pm
The top 10 drugs losing US exclusivity in 2024
Mar 11, 2024 3:00am
EU regulator says yes to Tavere's Filspari, several other meds
Feb 23, 2024 12:12pm
Vifor, CSL's latest acquisition, struggles on multiple fronts
Feb 14, 2024 10:10am